Business Description
PuriBlood Medical Co Ltd
ISIN : TW0006847007
Description
PuriBlood Medical Co Ltd is engaged in developing solutions for leukoreduction, cell separation, and anti-fouling materials. Its technology provides protection to support living beings from medical devices to daily protection. The products of the company include Leukoreduction, Cell Seperation, and P-tex.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.28 | |||||
| Equity-to-Asset | 0.68 | |||||
| Debt-to-Equity | 0.29 | |||||
| Debt-to-EBITDA | -1.15 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 11.09 | |||||
| Beneish M-Score | -0.68 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 25.5 | |||||
| 3-Year EPS without NRI Growth Rate | -124.7 | |||||
| 3-Year Book Growth Rate | -2.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 34.55 | |||||
| 9-Day RSI | 42.26 | |||||
| 14-Day RSI | 44.3 | |||||
| 6-1 Month Momentum % | 2.31 | |||||
| 12-1 Month Momentum % | -14.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.88 | |||||
| Quick Ratio | 3.27 | |||||
| Cash Ratio | 2.94 | |||||
| Days Inventory | 93.65 | |||||
| Days Sales Outstanding | 30.53 | |||||
| Days Payable | 32.1 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -17.9 | |||||
| Shareholder Yield % | 0.24 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 5.21 | |||||
| Operating Margin % | -40.24 | |||||
| Net Margin % | -41.19 | |||||
| FCF Margin % | 16.2 | |||||
| ROE % | -24.61 | |||||
| ROA % | -17.4 | |||||
| ROIC % | -28.11 | |||||
| ROC (Joel Greenblatt) % | -52.77 | |||||
| ROCE % | -20.6 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Price-to-Owner-Earnings | 92.5 | |||||
| PS Ratio | 12.54 | |||||
| PB Ratio | 8.68 | |||||
| Price-to-Tangible-Book | 9.32 | |||||
| Price-to-Free-Cash-Flow | 77.49 | |||||
| Price-to-Operating-Cash-Flow | 59.02 | |||||
| EV-to-EBIT | -28.38 | |||||
| EV-to-EBITDA | -33.51 | |||||
| EV-to-Revenue | 12.02 | |||||
| EV-to-FCF | 76.33 | |||||
| Price-to-Net-Current-Asset-Value | 22.37 | |||||
| Price-to-Net-Cash | 47.42 | |||||
| Earnings Yield (Greenblatt) % | -3.53 | |||||
| FCF Yield % | 1.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
PuriBlood Medical Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 125.268 | ||
| EPS (TTM) (NT$) | -3.63 | ||
| Beta | 0 | ||
| Volatility % | 23.07 | ||
| 14-Day RSI | 44.3 | ||
| 14-Day ATR (NT$) | 4.306358 | ||
| 20-Day SMA (NT$) | 111.975 | ||
| 12-1 Month Momentum % | -14.67 | ||
| 52-Week Range (NT$) | 104.5 - 135.5 | ||
| Shares Outstanding (Mil) | 14.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
PuriBlood Medical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
PuriBlood Medical Co Ltd Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
PuriBlood Medical Co Ltd Frequently Asked Questions
What is PuriBlood Medical Co Ltd(ROCO:6847)'s stock price today?
The current price of ROCO:6847 is NT$110.50. The 52 week high of ROCO:6847 is NT$135.50 and 52 week low is NT$104.50.
When is next earnings date of PuriBlood Medical Co Ltd(ROCO:6847)?
The next earnings date of PuriBlood Medical Co Ltd(ROCO:6847) is .
Does PuriBlood Medical Co Ltd(ROCO:6847) pay dividends? If so, how much?
PuriBlood Medical Co Ltd(ROCO:6847) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers